By Kirstie Saltsman, Ph.D. | December 15, 2014
Scratching an itch causes minor pain which prompts the brain to release serotonin. But serotonin also reacts with receptors on neurons that carry itch signals to the brain making itching worse.
Scratching an itch causes minor pain, which prompts the brain to release serotonin. But serotonin also reacts with receptors on neurons that carry itch signals to the brain, making itching worse.
Credit Zhou-Feng Chen, Ph.D., Washington University.

Scratching an itch brings short-lived relief but often makes the itching worse in the long-term. Now, a team of investigators led by Zhou-Feng Chen, Ph.D., director of the Center for the Study of Itch at the Washington University in St. Louis School of Medicine, has uncovered an explanation. The researchers found that serotonin, a molecule released by the brain in response to pain, such as the mild soreness caused by scratching, intensifies itch in mice. The report was published online October 30, 2014, in the journal Neuron.

Serotonin’s newly discovered role in itch suggested that deactivating the molecule could be an effective way to soothe the uncomfortable feeling. However, the body needs serotonin for many important functions, such as pain relief, bone metabolism, growth and sleep. A better strategy would be to block only its effects on itch by targeting serotonin receptors on itch-transmitting nerve cells.

To identify the receptor, Dr. Chen’s team injected mice with an itch-inducing protein called GRP, along with compounds that activate various receptors on nerve cells. Using this technique, they found that a serotonin receptor called 5-HT1A was responsible for strengthening the itch sensation. When the researchers blocked 5-HT1A in mice, the mice scratched less in response to GRP, further implicating the receptor in transmitting itch.

The approach has not yet been tested in people, but these results suggest that blocking the 5-HT1A receptor could be an effective strategy for treating the often-debilitating itch that characterizes chronic conditions like psoriasis and eczema.

# # #

This work was supported by the NIH’s NIAMS (grant R01-AR056318), the National Institute on Drug Abuse and the National Institute of General Medical Sciences. The National Natural Science Foundation of China also contributed support.

Zhao ZQ, Liu XY, Jeffry J, Karunarathne WKA, Li JL, Munanairi A, Zhou XY, Li H, Sun YG, Wan L, Wu ZY, Kim S, Huo FQ, Mo P, Barry DM, Zhang CK, Kim JY, Gautam N, Renner KJ, Li YQ, Chen ZF. Descending control of itch transmission by the serotonergic system via 5-HT1A-facilitated GRP-GRPR signaling. Neuron. vol. 84 (4), Nov. 19, 2014. Published online Oct. 30, 2014.

The mission of the NIAMS, a part of the U.S. Department of Health and Human Services' National Institutes of Health, is to support research into the causes, treatment and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. For more information about the NIAMS, call the information clearinghouse at (301) 495-4484 or (877) 22-NIAMS (free call) or visit the NIAMS website at

Last Reviewed: